September 2025
1. PALMA RH, Soares RGL, Meinerz G, Keitel E, et al
   Current epidemiological overview of glomerulonephritis in Latin America: a systematic literature review.
   J Nephrol. 2025 Sep 16. doi: 10.1007/s40620-025-02418.
   

   >> Share

   
   
2. PACKBIERS M, Hahm A, Riebeling T, Brasen JH, et al
   Treatment of recurrent IgA nephropathy after kidney transplantation with targeted-release budesonide - a case report.
   J Nephrol. 2025 Sep 12. doi: 10.1007/s40620-025-02405.
   

   >> Share

   
   
3. VISWANATHAN S, Seshadri J, Kurien AA, Palani Baskar HD, et al
   An observational study on mesangial C4d staining as a prognostic tool in IgA nephropathy.
   J Nephrol. 2025 Sep 9. doi: 10.1007/s40620-025-02410.
   

   >> Share

   
   August 2025
4. EBRAHIMI N, Geetha D, Reyes-Bahamonde J, Zuppan CW, et al
   Correction: Effective management of lupus nephritis using a novel combination therapy with low-dose steroids: a case report.
   J Nephrol. 2025 Aug 26. doi: 10.1007/s40620-025-02408.
   

   >> Share

   
   
5. EBRAHIMI N, Geetha D, Reyes-Bahamonde J, Zuppan CW, et al
   Effective management of lupus nephritis using a novel combination therapy with low-dose steroids: a case report.
   J Nephrol. 2025 Aug 8. doi: 10.1007/s40620-025-02361.
   

   >> Share

   
   July 2025
6. PONTICELLI C, Moroni G
   Correction: Targeting autophagy in autoimmune glomerular diseases.
   J Nephrol. 2025 Jul 29. doi: 10.1007/s40620-025-02360.
   

   >> Share

   
   
7. LI J, Tai H, Yang B, Xu J, et al
   Efficacy and safety of TRF-budesonide in IgA nephropathy treatment: a meta-analysis.
   J Nephrol. 2025 Jul 28. doi: 10.1007/s40620-025-02341.
   

   >> Share

   
   
8. BADAWI MH, Nagy E, Wafa EW, El-Husseini A, et al
   Impact of SGLT2i on bone health in patients with lupus nephritis: randomized double blinded placebo-controlled clinical trial.
   J Nephrol. 2025 Jul 13. doi: 10.1007/s40620-025-02351.
   

   >> Share

   
   
9. HIRANO K, Ikenoue T, Seki T, Komukai S, et al
   Development and validation of personalized risk prediction models for patients with IgA nephropathy: a nationwide multicenter cohort study.
   J Nephrol. 2025 Jul 11. doi: 10.1007/s40620-025-02338.
   

   >> Share

   
   
10. QI F, Zeng HQ, Zhu L, Zhou P, et al
    Efficacy of methylprednisolone pulse therapy in Chinese children with IgA vasculitis-associated nephritis (IgAVN).
    J Nephrol. 2025;38:1565-1572.
    

    >> Share

    
    June 2025
11. DECAESTECKER A, Daniel A, Malbranque Z, Wayolle N, et al
    Crescentic glomerulonephritis associated with myelodysplatic syndrome and visceral leishmaniasis.
    J Nephrol. 2025 Jun 19. doi: 10.1007/s40620-025-02329.
    

    >> Share

    
    
12. GOGGINS E, DeLaat A, Barr B, Taliercio J, et al
    Clinical uptake of an antigen-based approach to membranous nephropathy: a survey of general nephrologists and glomerular disease experts.
    J Nephrol. 2025 Jun 11. doi: 10.1007/s40620-025-02313.
    

    >> Share

    
    May 2025
13. ISHIGAKI S, Takei H, Hiramoto K, Kaneko Y, et al
    Plasma cell-rich interstitial nephritis without glomerulonephritis in granulomatosis with polyangiitis.
    J Nephrol. 2025 May 30. doi: 10.1007/s40620-025-02318.
    

    >> Share

    
    April 2025
14. MATHEW GG
    Molecular markers or clinical end points? What is the optimal monitoring tool for low-dose rituximab in membranous nephropathy in resource-limited settings?
    J Nephrol. 2025 Apr 7. doi: 10.1007/s40620-025-02273.
    

    >> Share

    
    
15. TANG C, Si FL, Chen P, Hou WY, et al
    Effectiveness and safety of finerenone in non-diabetic patients with IgA nephropathy.
    J Nephrol. 2025 Apr 1. doi: 10.1007/s40620-025-02240.
    

    >> Share

    
    March 2025
16. XU L, Wu C, Li G
    Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review.
    J Nephrol. 2025 Mar 26. doi: 10.1007/s40620-025-02261.
    

    >> Share

    
    
17. CLAUDIO P, Gabriella M
    Targeting autophagy in autoimmune glomerular diseases.
    J Nephrol. 2025 Mar 19. doi: 10.1007/s40620-025-02267.
    

    >> Share

    
    
18. MAHMOUD NB, Sahtout W, Ghabi F, Salem MB, et al
    Prognostic value of C3-exclusive deposits in post-infectious glomerulonephritis in adults: an observational cohort in Tunisia.
    J Nephrol. 2025 Mar 7. doi: 10.1007/s40620-025-02262.
    

    >> Share

    
    
19. BONELLI GD, Sciascia S, Calatroni M, L'imperio V, et al
    Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort.
    J Nephrol. 2025;38:643-653.
    

    >> Share

    
    
20. EISINGER F, Neumann M, Worn M, Fritsche A, et al
    Comparison of GFR estimation in patients with diabetes mellitus using the EKFC and CKD-EPI equations.
    J Nephrol. 2025;38:707-716.
    

    >> Share

    
    February 2025
21. SRIDHARAN K, Gopal B, Wilson S, Pham A, et al
    Obinutuzumab in Rituximab-resistant and recurrent membranous nephropathy: a case-series.
    J Nephrol. 2025 Feb 20. doi: 10.1007/s40620-025-02224.
    

    >> Share

    
    
22. UMEZAWA Y, Aoki R, Ichikawa D, Suzuki Y, et al
    Glomerular galactose-deficient IgA1 and apoptosis inhibitor of macrophage staining in secondary IgA nephropathy associated with alcoholic cirrhosis.
    J Nephrol. 2025 Feb 13. doi: 10.1007/s40620-025-02213.
    

    >> Share

    
    January 2025
23. KANG D, Zhang M, Chen Z, Zheng Z, et al
    Clinicopathological characteristics and prognosis of lupus nephritis patients with positive anti-ribonucleoprotein antibodies.
    J Nephrol. 2025 Jan 20. doi: 10.1007/s40620-024-02177.
    

    >> Share

    
    December 2024
24. JAFRY NH, Butt N, Mubarak M, Akhtar SF, et al
    Anti-glomerular basement membrane disease complicated by malaria during pregnancy with successful maternal and fetal outcomes: a case report.
    J Nephrol. 2024;37:2655-2660.
    

    >> Share

    
    November 2024
25. YANG M, Liu X, Chen Y, Chen X, et al
    Validation and modification of renal risk score for prediction of long-term kidney survival in patients with MPO-ANCA-associated glomerulonephritis.
    J Nephrol. 2024 Nov 22. doi: 10.1007/s40620-024-02134.
    

    >> Share

    
    
26. KANBAY M, Ozbek L, Guldan M, Copur S, et al
    Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant medicine.
    J Nephrol. 2024 Nov 20. doi: 10.1007/s40620-024-02149.
    

    >> Share

    
    
27. QUEYREL-MORANNE V, Daniel L, Moranne O
    Focal segmental glomerulosclerosis in a native African patient with systemic lupus erythematosus.
    J Nephrol. 2024 Nov 12. doi: 10.1007/s40620-024-02106.
    

    >> Share

    
    October 2024
28. ELAHI T, Ahmed S, Ahmed E, Mubarak M, et al
    Clinicopathological characteristics and outcomes of adult patients with idiopathic membranoproliferative glomerulonephritis according to an immunofluorescence-based classification.
    J Nephrol. 2024 Oct 14. doi: 10.1007/s40620-024-02083.
    

    >> Share

    
    
29. ZHANG Q, Zhou F, Zhao Y, Luo C, et al
    The uncertain correlation of ANCAs in patients with lupus nephritis and crescents, an experience from Chinese centers.
    J Nephrol. 2024 Oct 10. doi: 10.1007/s40620-024-02085.
    

    >> Share

    
    
30. BARAGETTI I, Del Vecchio L, Ferrario F, Alberici F, et al
    The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort.
    J Nephrol. 2024 Oct 6. doi: 10.1007/s40620-024-02071.
    

    >> Share

    
    
31. HERNANDEZ-ANDRADE A, Nordmann-Gomes A, Juarez-Cuevas B, Zavala-Miranda MF, et al
    Urine epidermal growth factor as a biomarker for kidney function recovery and prognosis in glomerulonephritis with severe kidney function impairment.
    J Nephrol. 2024 Oct 4. doi: 10.1007/s40620-024-02068.
    

    >> Share

    
    July 2024
32. YANG T, Shi Y, Wang Y, Feng Y, et al
    Hydroxychloroquine blood concentrations and effects in Chinese patients with IgA nephropathy.
    J Nephrol. 2024 Jul 24. doi: 10.1007/s40620-024-02029.
    

    >> Share

    
    
33. BALTU D, Serin O, Aksu T, Hizarcioglu Gulsen H, et al
    Membranoproliferative glomerulonephritis in a patient with lysinuric protein intolerance: lesson for the clinical nephrologist.
    J Nephrol. 2024 Jul 17. doi: 10.1007/s40620-024-02018.
    

    >> Share

    
    
34. PERNA A, Campise M, Alfieri CM, Regalia A, et al
    Kidney transplantation in patients with ANCA-associated vasculitis is associated with a high incidence of post-transplant cancer.
    J Nephrol. 2024;37:1611-1619.
    

    >> Share

    
    June 2024
35. SARA M, Anna S, Lorenzo B, Valentina B, et al
    Macrophage activation syndrome secondary to systemic lupus erythematosus: lesson for the clinical nephrologist.
    J Nephrol. 2024 Jun 28. doi: 10.1007/s40620-024-01997.
    

    >> Share

    
    
36. RATNAYAKE C, Crombie T, Fraenkel M, McMahon LP, et al
    Haemoptysis in a stable kidney transplant patient previously seropositive for anti-GBM and ANCA glomerulonephritis.
    J Nephrol. 2024 Jun 18. doi: 10.1007/s40620-024-01993.
    

    >> Share

    
    
37. LIM RS, Yeo SC
    EXternal validation of international IgA nephropathy prediction tool in a Singapore CohorT (EXIST Study).
    J Nephrol. 2024 Jun 13. doi: 10.1007/s40620-024-01985.
    

    >> Share

    
    
38. LIU L, de Leeuw K, der Meer BD, van Goor H, et al
    Expression of myxovirus resistance protein A in lupus nephritis and other glomerular nephropathies.
    J Nephrol. 2024 Jun 5. doi: 10.1007/s40620-024-01971.
    

    >> Share

    
    
39. CUGNO M, Mancuso MC, Depetri F, Peyvandi F, et al
    IgM autoantibodies to complement factor H in C3 glomerulopathy.
    J Nephrol. 2024 Jun 1. doi: 10.1007/s40620-024-01961.
    

    >> Share

    
    May 2024
40. NAGARAJAH S, Saleh QW, Rasmussen M, Tepel M, et al
    Long non-coding RNA MGAT3 in kidney transplant recipients with immunoglobulin A nephropathy.
    J Nephrol. 2024;37:1133-1135.
    

    >> Share

    
    
41. CETINKAYA H, Gursu M, Yazici H, Cebeci E, et al
    Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?
    J Nephrol. 2024;37:923-932.
    

    >> Share

    
    April 2024
42. DAVIES E, Chetwynd A, McDowell G, Rao A, et al
    The current use of proteomics and metabolomics in glomerulonephritis: a systematic literature review.
    J Nephrol. 2024 Apr 30. doi: 10.1007/s40620-024-01923.
    

    >> Share

    
    
43. SHAHEEN M, Bharat A, Friedman AN, Guo S, et al
    ALECT2 amyloidosis with concurrent IgG4-related interstitial nephritis, membranous nephropathy and diabetic kidney disease: a case report and literature review.
    J Nephrol. 2024 Apr 17. doi: 10.1007/s40620-024-01924.
    

    >> Share

    
    March 2024
44. ROBERT JT, Rajaram A, Fiset PO, Bernard C, et al
    Class V lupus nephritis recurrence with histologic resolution in a kidney transplant recipient on a pregnancy-adapted immunosuppression protocol: a lesson for the clinical nephrologist.
    J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-024-01920.
    

    >> Share

    
    
45. HU D, Wang Z, Wang S, Li Y, et al
    Lymphatic vessels in patients with crescentic glomerulonephritis: association with renal pathology and prognosis.
    J Nephrol. 2024 Mar 25. doi: 10.1007/s40620-024-01903.
    

    >> Share

    
    
46. REN W, Sun J, Zhang L, He W, et al
    Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01893.
    

    >> Share

    
    
47. ARNAERT S, Schepens N, Deleu L, Malfait T, et al
    Case report: renal recovery in Goodpasture's syndrome treated with rituximab.
    J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-024-01892.
    

    >> Share

    
    
48. VAZ DE CASTRO PAS, Amaral AA, Almeida MG, Selvaskandan H, et al
    Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis.
    J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01874.
    

    >> Share

    
    February 2024
49. CHRISTODOULOU M, Moysidou E, Lioulios G, Stai S, et al
    The prognostic value of two histopathologic classification models of ANCA-associated glomerulonephritis: a prospective study.
    J Nephrol. 2024 Feb 12. doi: 10.1007/s40620-023-01855.
    

    >> Share

    
    
50. OCHIAI S, Kikuchi M, Kaikita K, Fujimoto S, et al
    Rapidly progressive glomerulonephritis due to IgA nephropathy accompanied by collagenofibrotic glomerulopathy. A nephrology picture.
    J Nephrol. 2024 Feb 6. doi: 10.1007/s40620-023-01875.
    

    >> Share

    
    January 2024
51. TRIMARCHI H, Fervenza FC, Coppo R
    Points of view in nephrology: personalized management of IgA nephropathy, beyond KDIGO.
    J Nephrol. 2024 Jan 18. doi: 10.1007/s40620-023-01833.
    

    >> Share

    
    
52. HE WJ, Wang J, Liu N, Li GY, et al
    The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience.
    J Nephrol. 2024 Jan 16. doi: 10.1007/s40620-023-01839.
    

    >> Share

    
    December 2023
53. SCHENA FP, Cox SN
    Correction to: Is it time for personalized therapy in IgA nephropathy patients?
    J Nephrol. 2023 Dec 8. doi: 10.1007/s40620-023-01861.
    

    >> Share

    
    
54. BOUSSETTA A, Jellouli M, Hajji M, Rekaya S, et al
    A membranous nephropathy in a 5 year-old boy: and if that's not all? A nephrology quiz.
    J Nephrol. 2023 Dec 6. doi: 10.1007/s40620-023-01821.
    

    >> Share

    
    November 2023
55. ALBERTAZZI V, Fontana F, Giberti S, Aiello V, et al
    Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-up.
    J Nephrol. 2023 Nov 13. doi: 10.1007/s40620-023-01803.
    

    >> Share

    
    
56. BANJONGJIT A, Thammathiwat T, Townamchai N, Kanjanabuch T, et al
    SARS-CoV-2 infection associated with antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN): a systematic review and two case reports.
    J Nephrol. 2023 Nov 6. doi: 10.1007/s40620-023-01777.
    

    >> Share

    
    
57. RUSSWURM M, Kortus-Goetze B, Maier-Giebing T, Groene HJ, et al
    General prognostic models may neglect vulnerable subgroups in ANCA-associated vasculitis.
    J Nephrol. 2023;36:2269-2280.
    

    >> Share

    
    
58. GOTO K, Imaizumi T, Hamada R, Ishikura K, et al
    Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017.
    J Nephrol. 2023;36:2257-2267.
    

    >> Share

    
    
59. XIONG L, Liu L, Tao Y, Guo H, et al
    Clinical significance of IgM and C3 deposition in children with primary immunoglobulin A nephropathy.
    J Nephrol. 2023;36:2213-2222.
    

    >> Share

    
    
60. RAO IR, Kolakemar A, Shenoy SV, Prabhu RA, et al
    Hydroxychloroquine in nephrology: current status and future directions.
    J Nephrol. 2023;36:2191-2208.
    

    >> Share

    
    
61. SCURT FG, Hirschfeld V, Ganz M, Mertens PR, et al
    Low levels of complement factor C3 at diagnosis can predict outcome in antineutrophil antibody associated vasculitis.
    J Nephrol. 2023;36:2281-2293.
    

    >> Share

    
    
62. WANG F, Jin Y, Zhou F, Luo L, et al
    Urinary isomorphic red blood cells for the prediction of disease severity and renal outcomes in MPO-ANCA-associated vasculitis: a retrospective cohort study.
    J Nephrol. 2023;36:2295-2304.
    

    >> Share

    
    
63. ROCCATELLO D, Careddu A, Ferro M, Naretto C, et al
    The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy.
    J Nephrol. 2023;36:2223-2231.
    

    >> Share

    
    
64. ALVAREZ L, Kambham N, Su R
    Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan.
    J Nephrol. 2023;36:2365-2370.
    

    >> Share

    
    October 2023
65. LIU Z, Wan C, Cao Y, Liu S, et al
    Distribution spectrum and clinical significance of glomerular exostosin (EXT1) deposits in PLA2R-positive membranous nephropathy.
    J Nephrol. 2023 Oct 26. doi: 10.1007/s40620-023-01779.
    

    >> Share

    
    
66. PALA C, Parenti E, Vizzini G, Gianfreda D, et al
    Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab.
    J Nephrol. 2023 Oct 17. doi: 10.1007/s40620-023-01789.
    

    >> Share

    
    
67. MONGERA N, Passler W, Sethi S, Kozakowski N, et al
    A case of protocadherin FAT1-positive membranous nephropathy secondary to hematopoietic stem-cell transplantation.
    J Nephrol. 2023 Oct 10. doi: 10.1007/s40620-023-01786.
    

    >> Share

    
    September 2023
68. PAOLO SF, Natasha CS
    Is it time for personalized therapy in IgA nephropathy patients?
    J Nephrol. 2023 Sep 22. doi: 10.1007/s40620-023-01745.
    

    >> Share

    
    
69. AI S, Yan X, Zhao X, Ye W, et al
    Malignancy-associated membranous nephropathy: focus on diagnosis and treatment.
    J Nephrol. 2023 Sep 15. doi: 10.1007/s40620-023-01751.
    

    >> Share

    
    
70. BAIER E, Kluge IA, Hakroush S, Tampe B, et al
    Low hemoglobin levels are associated with Bowman's capsule rupture and peritubular capillaritis in ANCA-associated renal vasculitis: a link of vascular injury to anemia?
    J Nephrol. 2023 Sep 7. doi: 10.1007/s40620-023-01748.
    

    >> Share

    
    
71. DIRIM AB, Agargun BF, Hurdogan O, Ozluk Y, et al
    Two cases of IgA nephropathy after splenectomy: spleen as a silent culprit in the pathogenesis of IgA nephropathy.
    J Nephrol. 2023 Sep 4. doi: 10.1007/s40620-023-01764.
    

    >> Share

    
    June 2023
72. WATANABE H, Yamana H, Okada A, Matsui H, et al
    Therapeutic plasma exchange for anti-glomerular basement membrane disease with dialysis-dependent kidney failure without diffuse alveolar hemorrhage.
    J Nephrol. 2023 Jun 24. doi: 10.1007/s40620-023-01695.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share